You are here

Ocugen

Next-generation Covid-19 vaccines currently being tested

Clinical Trials Arena

Thu, 04/10/25 - 11:40 am

Traditional gene therapies are uber-niche. Ocugen hopes to change that.

Pharma Voice

Wed, 04/17/24 - 11:14 am

Ocugen sniffs out COVID-19 vaccine opportunity, landing rights to nasal candidate with India authorization

Fierce Pharma

Tue, 10/4/22 - 10:42 am

intranasal vaccines

Merck, Emergent, Affinivax and Ocugen Level Up in Vaccine Development

BioSpace

Tue, 06/21/22 - 12:02 pm

Emergent BioSolutions

chikungunya virus

pneumococcal disease

FDA lifts hold on Ocugen's COVID-19 vaccine trial. But is it too late for the shot?

Fierce Pharma

Mon, 05/23/22 - 10:14 am

FDA warns small biotech Ocugen of potential $10K fines for failing to post trial results

Endpoints

Mon, 04/25/22 - 10:46 am

clinical trials

Vaccine Stocks Are Rising, but This Biotech Is Monday's Big Nasdaq Winner

Motley Fool

Mon, 12/20/21 - 10:57 am

Moderna Therapeutics

Intra-Cellular Therapies

Ocugen hits another snag in bringing its Bharat Biotech-partnered Covid-19 vaccine to the US

Endpoints

Mon, 11/29/21 - 10:57 am

Is Ocugen About to Beat Moderna in This One Market?

Motley Fool

Fri, 11/12/21 - 10:35 am

Moderna Therapeutics

This Surprising FDA Announcement Could Be Huge for Ocugen

Motley Fool

Fri, 11/5/21 - 09:43 am

2 Biotech Stocks That Could Go Parabolic This Week

Motley Fool

Mon, 10/25/21 - 10:57 am

Aurinia Pharmaceuticals

Ocugen preps filings for COVID-19 vaccine Covaxin on new data

Pharmaforum

Mon, 07/5/21 - 10:04 pm

Ocugen plans to seek full approval for Covaxin in US

Pharmaceutical Business Review

Fri, 06/11/21 - 10:51 am

Ocugen On Track to Bring Bharat Biotech's COVAXIN to US Market With Strong Data

BioSpace

Fri, 04/23/21 - 11:18 am

Valneva joins the phase 3 Covid-19 vaccine club

EP Vantage

Thu, 04/22/21 - 10:47 am

clinical trials

Can COVID Vaccine Latecomer Ocugen Beat Pfizer and Moderna?

Motley Fool

Tue, 02/9/21 - 11:25 am

Battered and out of options, Histogenics turns to eye drug developer Ocugen for reverse merger

Endpoints

Mon, 04/8/19 - 12:01 pm

Ocugen’s Dry Eye Disease Therapy Could Compete with Allergan and Shire

Xtalks

Wed, 03/21/18 - 10:55 am

dry eye disease

How this biotech plans to go up against big pharma with its eye disease products

Drug Delivery Business News

Sat, 12/30/17 - 10:38 am